Search

Author/Creator Cheok, Meyling

2. Bimodal expression of RHOH during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapy. Issue 2 (20th January 2021)

Authors:
Galiègue‐Zouitina, Sylvie; Fu, Qiangwei; Carton‐Latreche, Céline; Poret, Nicolas; Cheok, Meyling; Leprêtre, Frédéric; Figeac, Martin; Quesnel, Bruno; El Bouazzati, Hassiba; Shelley, Carl S
Journal:
EJHaem
Issue:
Volume 2:Issue 2(2021)
Page Start:
196
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Neurofibromatosis‐1 gene deletions and mutations in de novo adult acute myeloid leukemia. Issue 4 (5th March 2013)

Authors:
Boudry‐Labis, Elise; Roche‐Lestienne, Catherine; Nibourel, Olivier; Boissel, Nicolas; Terre, Christine; Perot, Christine; Eclache, Virginie; Gachard, Nathalie; Tigaud, Isabelle; Plessis, Ghislaine; Cuccuini, Wendy; Geffroy, Sandrine; Villenet, Céline; Figeac, Martin; Leprêtre, Frederic; Rennevill...
Journal:
American journal of hematology
Issue:
Volume 88:Issue 4(2013:Apr.)
Page Start:
306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML. (May 2017)

Authors:
Mohamed, Aminetou Mint; Balsat, Marie; Koering, Catherine; Maucort-Boulch, Delphine; Boissel, Nicolas; Payen-Gay, Lea; Cheok, Meyling; Mortada, Hussein; Auboeuf, Didier; Pinatel, Christiane; El-Hamri, Mohamed; Tigaud, Isabelle; Hayette, Sandrine; Dumontet, Charles; Cros, Emeline; Flandrin-Gresta,...
Journal:
Leukemia research
Issue:
Volume 56(2017:May)
Page Start:
21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗